Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma
Kaidong Liu, Yiding Geng, Linzhu Wang, et al.
Molecular Oncology (2022) Vol. 16, Iss. 16, pp. 3034-3051
Open Access | Times Cited: 16

Showing 16 citing articles:

Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies
Jay Z. Natu, Ganji Purnachandra Nagaraju
Cancer Letters (2023) Vol. 573, pp. 216382-216382
Open Access | Times Cited: 34
Therapeutic Targeting of DNA Replication Stress in Cancer
Long Gu, Robert J. Hickey, Linda H. Malkas
Genes (2023) Vol. 14, Iss. 7, pp. 1346-1346
Open Access | Times Cited: 15
Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma
Ashu Shah, Rahat Jahan, Sophia G. Kisling, et al.
Cancer Letters (2024) Vol. 598, pp. 217097-217097
Closed Access | Times Cited: 4
Aronia Berry Extract Modulates MYD88/NF-kB/P-Glycoprotein Axis to Overcome Gemcitabine Resistance in Pancreatic Cancer
Yuan Li, Caiming Xu, Haiyong Han, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 911-911
Open Access | Times Cited: 4
Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma
Silje Beckinger, Tina Daunke, Leon Aldag, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Large-scale machine learning analysis reveals DNA-methylation and gene-expression response signatures for gemcitabine-treated pancreatic cancer
Adeolu Z. Ogunleye, Chayanit Piyawajanusorn, Ghita Ghislat, et al.
Health Data Science (2023) Vol. 4
Open Access | Times Cited: 8
Gemcitabine‐Loaded Injectable Hydrogel for Localized Breast Cancer Immunotherapy
Mahdieh Shokrollahi Barough, Amir Seyfoori, Esfandyar Askari, et al.
Advanced Functional Materials (2024)
Open Access | Times Cited: 3
Novel silicene-mesoporous silica nanoparticles conjugated Gemcitabine induced cellular apoptosis via upregulating NF-κB p65 nuclear translocation suppresses pancreatic cancer growth in vitro and in vivo
Yuhang Chen, Chien‐shan Cheng, Peiwen Yang, et al.
Nanotechnology (2024) Vol. 35, Iss. 25, pp. 255101-255101
Open Access | Times Cited: 2
Prognostic evaluation of pancreatic cancer based on the model of chemo-radiotherapy resistance-related genes
Hui‐Chuan Sun, Weigang Zhang, Yunqian Chu, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 3, pp. 1525-1545
Open Access | Times Cited: 3
AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor
Komala Ingle, Joseph F. LaComb, Lee M. Graves, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294065-e0294065
Open Access | Times Cited: 3
Mechanisms underlying the changes in acetaldehyde dehydrogenase 1 in cholangiocarcinoma
Ding Bai, Yinghui Song, Sulai Liu, et al.
Journal of Cancer (2023) Vol. 14, Iss. 17, pp. 3203-3213
Open Access | Times Cited: 2
Individualized detection of TMPRSS2-ERG fusion status in prostate cancer: a rank-based qualitative transcriptome signature
Yawei Li, Hang Su, Kaidong Liu, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access
Bulk anda single-cell transcriptome profiling reveals the molecular characteristics of T cell-mediated tumor killing in pancreatic cancer
Yinwei Dai, Ya-ting Pan, Danfeng Lin, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27216-e27216
Open Access
Niraparib perturbs autophagosome-lysosome fusion in pancreatic ductal adenocarcinoma and exhibits anticancer potential against gemcitabine-resistant PDAC
Zehui Yao, Huihui Zhang, Kewei Huang, et al.
Translational Oncology (2024) Vol. 51, pp. 102206-102206
Closed Access
Cellular crosstalk of regulatory T cells in pancreatic ductal adenocarcinoma
Xuqing Shi, Hangqi Liu, Zhiyong Liang
Journal of Pancreatology (2023) Vol. 7, Iss. 2, pp. 131-140
Open Access | Times Cited: 1
The Expanding Roles of Long Non‐Coding RNAs in Pancreatic Cancer
Yu Yan, Danzhu Wu, Liyuan Yang, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 12
Open Access | Times Cited: 1
Page 1

Scroll to top